More than science
Meet the people behind CanChip
Why replacing animal testing became personal, not just scientific.
Tumor-on-Chip • Human-relevant data • 3D microfluidics • Oncology validation • Fraunhofer-certified • No animal testing
We built CanChip
because the system was failing patients.
When Ghazaleh Madani’s mother was diagnosed with cancer, she experienced firsthand what millions of patients and families face every year: a system that moves painfully slowly, with treatments that work in the lab but fail in the clinic. As a biochemist, she knew why. The models used to develop cancer drugs are fundamentally disconnected from human biology. Omid Nejati had spent years in stem cell research and tissue engineering, watching promising compounds fail in clinical trials that should have been screened out years earlier. The problem wasn’t a lack of science – it was the wrong tools. Together, they founded CanChip with one goal: replace the models that are failing patients with systems that actually reflect human tumor biology. Not as an academic project – as a company that delivers results to the pharmaceutical industry.
Mission
Make cancer drug discovery faster, more precise, and dramatically less expensive – without relying on animal models.
Vision
To become Europe’s leading oncology validation platform – moving from custom study execution today to a proprietary human tumor-response intelligence layer that compounds in value with every program we run.
The people
behind CanChip.
Ghazaleh Madani
CEO & Founder
MSc Biochemistry & Molecular Biology, University of Potsdam. Background in cancer cell research and immunization. Founded CanChip in 2023 after her master’s thesis work in preclinical R&D exposed the gap between animal models and clinical outcomes.
Dr. Omid Nejati
Scientific Director
Dr. Omid PhD candidate in Stem Cells & Tissue Engineering. 30+ published articles on cancer, genetics, nanomedicine, and organ-on-chip systems. Expert in molecular oncology, microfluidic systems, 3D bioprinting, and drug delivery. Former ex-vivo lab supervisor and nanoparticle researcher.
Explore Dr. Nejati’s publications on Google Scholar → Omid Nejati – Google Scholar
Zhina Mazhari
Laboratory Expert
MSc Molecular Biology & Genetics. GLP-certified. 7+ years of experience in molecular laboratory management and quality assurance in pharmaceutical environments. Joined CanChip in 2024.
Backed by public funding.
Open to strategic investors.
CanChip is co-funded by the European Union. We are selectively open to strategic investment partnerships that accelerate our path to becoming Europe’s leading oncology validation platform.